chromosome segregation

Can Faulty Chromosome Segregation be Targeted in Cancer Therapy?

Yes, targeting faulty chromosome segregation presents a promising avenue for cancer therapy. Strategies include:
Inhibiting proteins involved in spindle assembly and function, such as Aurora kinases and Kinesin spindle protein (KSP).
Targeting the spindle assembly checkpoint to selectively kill aneuploid cancer cells.
Exploiting vulnerabilities in cancer cells with high levels of genomic instability by using PARP inhibitors.

Frequently asked queries:

What is Chromosome Segregation?
How Does Chromosome Segregation Go Wrong in Cancer?
What Are the Mechanisms Behind Faulty Chromosome Segregation?
Why is Aneuploidy Significant in Cancer?
What Role Do Tumor Suppressors and Oncogenes Play?
Can Faulty Chromosome Segregation be Targeted in Cancer Therapy?
What Are the Challenges in Targeting Chromosome Segregation?
How Can Cancer Patients Ensure They Get Enough Vitamins and Minerals?
What are the Symptoms of Fibroadenomas?
What Are Some Occupational Hazards Linked to Cancer?
How is Neuropathic Pain Different from Other Types of Pain?
What is the Role of Technology in Skill Enhancement?
What Role Does PD-L1 Play in Immunotherapy?
What is the Tumor Microenvironment (TME)?
What Are the Treatment Options for Organ Injury in Cancer Patients?
How Can Policy Changes Improve Cancer Care Accessibility?
What Role Do Healthcare Providers Play in Managing Fluid Intake for Cancer Patients?
What About Quality of Life?
What are the Steps Involved in Immunohistochemistry?
What are the Leptomeninges?
Top Searches
Brain Tumor Breast cancer cancer Cancer Genomics Chemotherapy hepatocellular carcinoma Lung Cancer Nanotechnology Non-Hodgkin’s Lymphoma Radiation-Induced Malignancies
Follow Us

Partnered Content Networks

Relevant Topics